A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it. The test, called Galleri, failed to lower the number of people diagnosed ...

Grail Inc.’s multi-cancer blood test, Galleri, failed to hit its primary goal in a large-scale National Health Service trial, ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in ...

The Alabama House on Tuesday passed two bills that would eliminate cost sharing for certain types of breast and prostate ...

While many people are familiar with mammograms and smear tests, prostate screening is talked about far less.To shed light on this important subject ahead of Prostate Cancer Awareness Month in March, ...

A prostate cancer committee has been accused of exaggerating the risks of screening. Advisers to Wes Streeting, the Health Secretary, rejected calls to offer targeted testing in November, arguing that ...

Grail's blood test for detecting cancer early failed to meet its main goal in a giant study being conducted with England’s ...

The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.

Blood tests are helpful for monitoring your overall health. But research suggests they can also give us clues about the ...

One way cancer specialists detect the disease is by examining cells and bodily fluids under a microscope, a time-consuming ...

"I'm nervous and a bit scared," the Disney Channel alum said.

The healthcare company said Thursday the test failed to meet the trial's target of a statistically significant reduction in Stage III and Stage IV cancer. The trial was designed to demonstrate ...